Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2543-2021Class II

The Instructions for Use (IFU) for: Carotid Patch and Gelsoft Patch vascular patches. FSN says Tapered...

Vascutek, Ltd. / initiated 2021-07-08 / Terminated / root cause: labeling and UDI

Vascutek, Ltd. began a recall of The Instructions for Use (IFU) for: Carotid Patch and Gelsoft Patch vascular patches. FSN says Tapered Carotid Patch 920875t on . FDA classified it as Class II and gives the reason as "The devices contained the IFU for distribution to ROW (rest of world) consignees rather than U.S. consignees". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2543-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Vascutek, Ltd.
Product
The Instructions for Use (IFU) for: Carotid Patch and Gelsoft Patch vascular patches. FSN says Tapered Carotid Patch 920875t
Product code
DXZ Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene
Reason for recall
The devices contained the IFU for distribution to ROW (rest of world) consignees rather than U.S. consignees.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
The recalling firm sent emails on 7/8/2021 to the two distributors that contained the Field Safety Notice and the correct IFU to be supplied with products distributed to the United States.
Quantity in commerce
159 total vascular grafts and patches
Distribution
Distribution was made to PR and Guam.
Product codes and lots
To be reported.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2543-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2542-2021Class IITerminatedVoluntary: Firm initiated
Z-2543-2021Class IITerminatedVoluntary: Firm initiated